Biomarker types and colorectal cancer
Biomarkers 101
Learn the basics about biomarkers and colorectal cancer, why testing is important, and what learning about your biomarker mutations can mean for your treatment options and cancer outcomes.
Biomarker type resource guide
This resource grid details the different types of biomarkers and how they relate to a colorectal cancer diagnosis and treatment.
The Alliance’s personalized treatment program
The Alliance and Perthera have partnered to provide personalized treatment options to stage III and IV patients with colorectal cancer.
If you recently had molecular/biomarker testing, your results will be analyzed with no additional testing required.
Call us at the Alliance’s Helpline at (877) 422-2030 to enroll.
Related reading
SidednessTop resources
Hope in the Details: How Heather’s Biomarker Opened New Treatment Paths
After a stage IV colorectal cancer diagnosis, Heather’s biomarker test revealed a critical mutation — opening the door to clinical trials and new hope.
Proposed budget cuts could strip health insurance from millions
A proposed federal budget could cut $715 billion from Medicaid, leaving 8.6 million Americans without insurance. Learn how this impacts cancer prevention, early detection, and survival—and what you can do to help protect care access.
Alliance Launches “Screen Smart” To Make Lifesaving Cancer Screenings Easier for Everyone
The Screen Smart initiative brings together insights from medical experts, researchers, and advocates to make colorectal cancer screening decisions easier for both patients and healthcare providers.